DOLEŽALOVÁ, Irena, J. CHLADEK, Eva KORIŤÁKOVÁ, Jan CHRASTINA and Milan BRÁZDIL. Prediction of vagal nerve stimulation efficacy - validation of statistic model on external data set, pilot study. 2020. ISSN 1351-5101.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Prediction of vagal nerve stimulation efficacy - validation of statistic model on external data set, pilot study
Authors DOLEŽALOVÁ, Irena (203 Czech Republic, guarantor, belonging to the institution), J. CHLADEK (203 Czech Republic), Eva KORIŤÁKOVÁ (203 Czech Republic, belonging to the institution), Jan CHRASTINA (203 Czech Republic) and Milan BRÁZDIL (203 Czech Republic).
Edition 2020.
Other information
Original language English
Type of outcome Conference abstract
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 6.089
RIV identification code RIV/00216224:14110/20:00118615
Organization unit Faculty of Medicine
ISSN 1351-5101
UT WoS 000534616801425
Keywords in English vagal nerve stimulation efficacy; prediction
Tags rivok
Tags International impact
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 13/8/2020 13:31.
Abstract
Vagal nerve stimulation (VNS) offers a possibility for a substantial seizure reduction in approximately 50% of implanted patients. However, there is a large group of patients who do not profit significantly from this therapy. At the moment, there is no widelyaccepted method for prediction of VNS efficacy based on pre-implantation data. Our group has developed and published a statistic classifier based on pre-implantation routine EEG, which was able to predict VNS response in a given patient with high accuracy. The crucial limitation of our previous work was its monocentric nature and the use of only one type of EEG recording system.
Links
NV19-04-00343, research and development projectName: Predikce Efektu Stimulace u pacientů s Epilepsií (PRESEnCE) (Acronym: PRESEnCE)
Investor: Ministry of Health of the CR
PrintDisplayed: 4/5/2024 01:28